Discover the leading AI drug discovery platforms shaping the future of pharmaceutical R&D for US biotech startups. Learn how these technologies accelerate innovation and bring new therapies to market faster.

This article explores the landscape of undervalued US biotech stocks, identifying companies with promising pipelines and market positions poised for over 15% growth by Q3 2025, offering strategic insights for investors.